OPPO Health Lab's Dr. Zeng Zijing Session on September 24: Technology Trends and Ecosystem Development of Consumer Electronics in Digital Healthcare

This Saturday morning, Zeng Zijing, Head of the OPPO Health Lab, will deliver a keynote presentation to discuss online OPPO’s latest technological trends, product design innovations, and ecosystem development in the field of digital health.

Scan the QR code above to register.

The innovation-driven Jiacheng Investment team sees:The new era of digital health, ushered in by biosensors, is unfolding.

Recently, the Jiacheng Investment team visited multiple laboratories at Harvard University, MIT, and Johns Hopkins University in the United States. They learned that various sensors are creating new scenarios for health monitoring and management, with an increasingly diverse range of biomarkers being tracked. For instance, sleep patterns can be monitored through respiration to predict Parkinson’s disease; gait analysis can be used to monitor medication efficacy in Parkinson’s patients, thereby assisting physicians in precise dosing; patient body movements on hospital beds can be monitored to alert nurses to reposition patients, thus preventing pressure ulcers; and detailed three-dimensional reconstructions of cardiac structures and scar distribution can be generated prior to surgery, enabling more precise cardiac interventions.

Continuous data monitoring and real-time online surveillance have become the new starting point for digital health; cloud-based sensors, combined with artificial intelligence modeling and algorithms, have emerged as the greatest productivity driver in digital health; the miniaturization of medical and healthcare devices, along with their integration with consumer electronics, has become a new trend for next-generation digital health products.In China, such a trend is emerging.

According to a report released by PwC in 2021, the market size of China’s healthcare and wellness industry has reached RMB 13 trillion, with a compound annual growth rate (CAGR) of 13%, making it the second-largest market globally. Many leading electronics technology companies have entered this sector. Since Apple launched the first-generation Apple Watch in 2014, wearable devices, represented by smartwatches, have gained increasing attention from various companies.

OPPO is one such example. In 2021, OPPO officially established its Health Laboratory, focusing on research in areas such as exercise health, cardiovascular health, sleep health, and mental health. Currently, it has formed strategic partnerships with multiple top-tier universities and medical institutions in China, carrying out more than 30 research projects across various fields including exercise health, cardiovascular health, sleep, sensors, and materials.

Dr. Zeng Zijing, as OPPO’s Vice President, President of the Health Business, and Head of the Health Lab, is responsible for building a health team comprising experts in health algorithms, sensors, data science, and biomedicine, thereby fostering a closed-loop OPPO health ecosystem.

Dr. Zijing Zeng returned to China in February 2021 to join OPPO as the Head of the Health Laboratory and was selected for the national “Innovative Talent” introduction program. Previously, he led the product design and R&D of Apple Watch sensors and other health-related products at Apple Inc., managing the R&D and engineering teams responsible for the development and manufacturing of health and fitness products. Prior to joining Apple, he worked at Thoratec (Abbott), where he was engaged in core R&D of heart pumps. Dr. Zeng has extensive long-term research experience in the health sector and is dedicated to the full-lifecycle development of consumer electronics and medical devices in this field. He possesses rich experience in leading scientific and engineering teams and is committed to innovation and commercialization in the health and medical technology sectors.

Dr. Zijing Zeng earned his bachelor’s degree from Tsinghua University and holds a Ph.D. in Cardiovascular Mechanics and Hemodynamics from the University of Pittsburgh.

September 24 (Beijing Time), this Saturday at 10:00 AM, Jiacheng Entrepreneurship Roundtable Session No. 152!We have joined hands with BioWorld and VCBeat,Major InvitationOPPO AVP, President of Health Business, Head of Health LabZeng Zijing, sharing online and interacting on OPPO's technological product innovations and future development trends in the field of digital health.

We will discuss:

1. What are the latest trends in the development of China's digital health industry, and what are the major opportunities and challenges?

2. What are the core technologies behind OPPO's products in the consumer health electronics sector?

3. In the field of digital health wearables, which indications or application scenarios are poised for the earliest market commercialization?

4. What are the latest research findings from OPPO in the areas of sports and fitness, cardiovascular health, sleep health, and mental health?

5. What are the competitive advantages of OPPO's health consumer products in China and internationally?

6. What new opportunities can technologies such as the Internet of Things (IoT), big data, cloud computing, and AI bring to health consumer products?

7. How will OPPO strategically position itself in the planning of consumer health products and the development of its data ecosystem in the future?

Get on board again!

Jiacheng Venture Capital’s “Flowing Banquet” is a high-end, private, and egalitarian networking platform designed for entrepreneurs.Here, you can meet outstanding peers from various fields. Since the launch of the Jiacheng Entrepreneurship Roundtable service in the second half of 2018, thanks to the strong support of our community members, we have held 151 roundtable sessions for entrepreneurs in Beijing, Shanghai, Hangzhou, and Shenzhen through online communities, live streams, and offline events and exchanges. To date, we have served tens of thousands of entrepreneurs and industry professionals, with nearly 1,000 entrepreneurs and industry experts sharing their insights on the Jiacheng Entrepreneurship Roundtable.

"Bio World" is a top-tier biotech self-media matrix in Chinese media.Its portfolio includes a matrix of self-media brands such as “BioWorld,” “E-Pharma World,” “E-Pharma Insights,” and “Academic Observer,” distributed across omnichannel platforms including WeChat, Toutiao, NetEase News, and The Paper. With nearly one million professional followers across the internet, this media matrix has garnered significant attention from top-tier scientists, experts, and senior industry executives in the Chinese-speaking market, thereby fostering a high-quality community for discussions on frontier trends in biotechnology, academic achievements, and industry developments.

VCBeat, founded in 2014, is a new-type industry service organization that leverages data as its foundation, research as its core, and brand media as its connector to facilitate the precise aggregation of industrial resources and help industry changemakers achieve rapid growth.Provides brand communication, research and consulting, data monitoring, and resource/project matchmaking services to enterprises, government industrial parks, investment institutions, and other entities within the industry chain.